Advertisement

Topics

Genentech Dumps Another $650M in New Haven Biotech Arvinas

19:00 EST 14 Nov 2017 | BioSpace

The companies have been working together since 2015, with Genentech licensing Arvinas’ platform for protein degradation to do some secretive R&D.

Original Article: Genentech Dumps Another $650M in New Haven Biotech Arvinas

NEXT ARTICLE

More From BioPortfolio on "Genentech Dumps Another $650M in New Haven Biotech Arvinas"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...